{"lastClose": 7.230000019073486, "len": 1094, "date": "2023-02-15", "alpha_1": -0.14454034345663913, "beta_1": 1.6551465473170361, "drawup_1": 1.5486725887776869, "natr_1": 12.204092476598541, "sup_1": -0.5638543101341392, "res_1": 0.2941447936582286, "bullPattern_1": ["HARAMI", "SHORTLINE"], "bearPattern_1": [], "rsi_1": 56.40327042742217, "adx_1": 32.582023086705355, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.09374174205949166, "stratHoldAlpha_1": 250.9351482443082, "stratHoldDrawdown_1": -0.633275019986673, "alpha_3mo": -0.7268419462642406, "beta_3mo": 2.098488327351916, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.204092476598541, "sup_3mo": -0.09174731623011437, "res_3mo": 0.0378054261254484, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 38.970589137613636, "adx_3mo": 26.01730953453187, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.7784505595643039, "stratHoldAlpha_3mo": 249.8836250081774, "stratHoldDrawdown_3mo": -0.4324904681069768, "Sector": "Health Care", "IPO Year": 2018.0, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 1035428906, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "alpha%_1": 0.4269416675314387, "beta%_1": 0.9032175186431333, "drawup%_1": 0.997225399400326, "natr%_1": 0.9998883440959218, "drawdown%_1": 0.07320091072623731, "stratHoldSharpe%_1": 0.3709058685039469, "stratHoldAlpha%_1": 0.33011198490135063, "stratHoldDrawdown%_1": 0.06019901167863578, "alpha%_3mo": 0.07598532530865731, "beta%_3mo": 0.9785584453315059, "drawup%_3mo": 0.8781422362246816, "natr%_3mo": 0.9998510555920697, "drawdown%_3mo": 2.7520141407389525e-05, "stratHoldSharpe%_3mo": 0.034286773120833364, "stratHoldAlpha%_3mo": 0.004178249337133686, "stratHoldDrawdown%_3mo": 2.7104235210676735e-05}